Localization of peptidylarginine deiminase type II in a stage-specific immature oligodendrocyte from rat cerebral hemisphere

被引:47
作者
Akiyama, K
Sakurai, Y
Asou, H
Senshu, T
机构
[1] Tokyo Metropolitan Inst Gerontol, Dept Bioactiv Regulat, Itabashi Ku, Tokyo 1730015, Japan
[2] Tokyo Metropolitan Inst Gerontol, Dept Neurol, Itabashi Ku, Tokyo 1730015, Japan
关键词
peptidylarginine deiminase; oligodendrocyte; myelin basic protein; protein deimination;
D O I
10.1016/S0304-3940(99)00678-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Myelin basic protein (MBP) is composed of multiple charged isomers as the products of various posttranslational modifications, The least cationic component contains six citrulline residues converted from arginine residues by peptidylarginine deiminase (PAD). The modified MBP differs markedly from unmodified MBP in the ability to aggregate acidic lipid vesicles, However, the localization of PAD in brain has remained rather elusive. We performed Western blotting and immunocytochemical analyses of PAD type II and found that it was present in stage-specific immature oligodendrocytes but not in either type-1 astrocytes or neu ro ns, We also confirmed that only the oligodendrocyte homogenate contained the PAD activity utilizing a sensitive method to detect citrulline-containing proteins. These data suggest that PAD type II localized in oligodendrocytes is responsible for deiminating MBP. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 55
页数:3
相关论文
共 18 条
  • [1] PAF analogues capable of inhibiting PAF acetylhydrolase activity suppress migration of isolated rat cerebellar granule cells
    Adachi, T
    Aoki, J
    Manya, H
    Asou, H
    Arai, H
    Inoue, K
    [J]. NEUROSCIENCE LETTERS, 1997, 235 (03) : 133 - 136
  • [2] AKIYAMA K, 1983, JPN J EXP MED, V53, P181
  • [3] Effect of posttranslational modifications to myelin basic protein on its ability to aggregate acidic lipid vesicles
    Boggs, JM
    Yip, PM
    Rangaraj, G
    Joo, E
    [J]. BIOCHEMISTRY, 1997, 36 (16) : 5065 - 5071
  • [4] Lees M.B., 1984, MYELIN, P197
  • [5] Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis
    Mastronardi, FG
    Mak, B
    Ackerley, CA
    Roots, BI
    Moscarello, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) : 349 - 358
  • [6] MYELIN IN MULTIPLE-SCLEROSIS IS DEVELOPMENTALLY IMMATURE
    MOSCARELLO, MA
    WOOD, DD
    ACKERLEY, C
    BOULIAS, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) : 146 - 154
  • [7] Murakami K, 1999, J NEUROSCI RES, V55, P382, DOI 10.1002/(SICI)1097-4547(19990201)55:3<382::AID-JNR13>3.0.CO
  • [8] 2-M
  • [9] ROTHNAGEL JA, 1984, METHOD ENZYMOL, V107, P624
  • [10] Sakurai Y, 1998, J NEUROSCI RES, V52, P17, DOI 10.1002/(SICI)1097-4547(19980401)52:1<17::AID-JNR3>3.0.CO